Abiopharma

🔍 Gray Timothy (Executive)

Company: NEXTNAV INC. (NN)

Report Date: 2026-03-19

Detailed Transactions and Holdings:

• Acquired 3,372 shares of Common Stock (Direct)
  Date: 2026-03-19 | Code: A | equity_swap_involved: 0 | shares_owned_after: 92,163.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 41,028 shares of Common Stock (Direct)
  Date: 2026-03-19 | Code: A | equity_swap_involved: 0 | shares_owned_after: 133,191.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 1,405 shares of Common Stock at $18.11 per share (Direct)
  Date: 2026-03-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 131,786.00 | transaction_form_type: 4 | Footnotes: F3
• Acquired 60,342 shares of Stock Option (Right to Buy) at $20.39 per share (Derivative)
  Date: 2026-03-19 | Code: A | Expires: 2036-03-19 | equity_swap_involved: 0 | shares_owned_after: 60,342.00 | transaction_form_type: 4 | Footnotes: F4

Footnotes:

• F1: Represents a bonus grant of restricted stock units ("RSUs"); 100% of the Bonus RSUs vested on March 19, 2026 (the grant date) (the "Bonus RSUs").
• F2: Represents a grant of RSUs that will vest over a four-year period. Subject to the Reporting Person's continued service through each of the applicable vesting dates, 1/4 of the RSUs shall vest on the one-year anniversary of March 19, 2026, and 1/16 of the RSUs shall vest quarterly in substantially equal installments thereafter.
• F3: The proceeds of this sale are intended to be used to satisfy tax withholding obligations in connection with the vesting of the Bonus RSUs.
• F4: Represents a grant of stock options (the "Options"). Subject to the Reporting Person's continued service through each of the applicable vesting dates, twenty five percent (25%) of the Options shall vest on the one-year anniversary of March 19, 2026, and the remaining portion shall vest in equal quarterly installments over the subsequent three years.